Obesity is a growing national health crisis, with nearly 40% of U.S. adults affected and about 10% having a severe form of ...

Mike DeWine and others in his orbit indicate that the governor will spend his final year in office working to burnish his ...

A major global study warns cancer cases and deaths will surge by 2050, with low- and middle-income countries facing the fastest rise without urgent action.

Obesity shaves two to four years off the average lifespan, while being very obese can shorten your lifespan by 8 to 10 years, according to a new analysis of 57 studies including nearly 900,000 people.

A 2021 Harvard University study that suggested reparations for Black Americans, along with systemic racism, may have played a significant role in the transmission of COVID-19 resurfaced ahead of the ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for ...

Americans in five states who get government help paying for groceries will see new limits starting Thursday on soda, candy ...

People probably don’t know how much sugar they’re eating. Up to 57 pounds per year, according to the American Heart ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

People older than 65 represent prime targets for weight loss medications. The prevalence of obesity hovers around 40% in ...

The Wegovy pill is a higher dose of the oral semaglutide Rybelsus (7 mg and 14 mg), FDA-approved in 2019 for treating type 2 diabetes (T2D) and in October 2025 for cardiovascular risk reduction in ...

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...